# Silence Therapeutics plc: Form SCHEDULE 13D/A, filed Apr 24, 2025

- Company: [Silence Therapeutics plc](/companies/sln.md) (CIK 1479615)
- Form: SCHEDULE 13D/A
- Filed: 2025-04-24
- Accepted by EDGAR: Apr 24, 2025, 09:28 ET
- Period: not reported
- Accession: 0001104659-25-038392
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1479615/000110465925038392/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479615/000110465925038392/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1479615/000110465925038392/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Apr 24, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-038392. Last ingested by Listed: Nov 5, 2026, 14:00 ET. No prices; not investment advice.